Related Experiment Video
Updated: May 31, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022
Nontuberculous Mycobacteria in Primary Ciliary Dyskinesia: A National Multicenter Cohort Study
Ophir Bar-On1,2, Saharon Less Elazari3, Haim Ben-Zvi4,5
1Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel, ophirbaron@tauex.tau.ac.il.
Introduction:
The prevalence and clinical significance of nontuberculous mycobacteria (NTM) in individuals with primary ciliary dyskinesia (PCD) remain unclear, with most data extrapolated from cystic fibrosis. This first national multicenter cohort study evaluating NTM in PCD patients aimed to determine the prevalence, species distribution, and clinical impact of NTM isolation.
Methods:
A retrospective, longitudinal study was conducted across four tertiary centers in Israel (2010-2024). Patients with confirmed PCD were evaluated for demographic, clinical, microbiological, and longitudinal lung function data. NTM species were classified by growth rate and pathogenicity. Each NTM-positive PCD patient was matched 1:1 to an NTM-negative PCD patient.
Results:
Of 231 patients with PCD, 24 (10.4%) had ≥1 positive NTM culture. Most isolates were slow-growing species, predominantly Mycobacterium simiae. Rapid-growing species, mainly Mycobacterium abscessus, were identified in patients with significantly lower forced expiratory volume in 1 s (FEV1) at the time of NTM isolation when compared with those harboring slow-growing species (43.5% vs. 82.3%, p = 0.03). Chronic isolation occurred in 25% of NTM-positive individuals. Longitudinal analysis showed no significant association between NTM status and FEV1 decline. Intravenous antibiotic use was not higher in NTM-positive patients and did not increase following NTM isolation. Only one patient fulfilled the criteria for NTM pulmonary disease.
Conclusion:
NTM isolation is not uncommon in PCD patients and is often intermittent, mostly by slow-growing species. NTM status was not associated with accelerated FEV1 decline, although rapid growers occurred predominantly in patients with poorer baseline lung function. Routine annual NTM surveillance appears reasonable to better determine prevalence and monitor outcomes.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
11:13Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
Published on: November 10, 2021
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction